PCAT1 and prostate carcinoma: PCAT1 was upregulated in docetaxel (DTX)-resistant PCa prostate cancer cells and in prostate cancer (PCa) patients, whereas PCa patients with higher serum PCAT1 levels had an unsatisfactory response to DTX chemotherapy.